Antimicrobials III: Protein Synthesis Inhibitors Flashcards
DNA/RNA Synthesis Inhibitors
Indirect: folate antagonists
Direct: Quinolones and other drugs
What do protein synthesis inhibitors target?
bacterial ribosome–> prevents growth
Most are bacteriostatic
some are bactericidal
What are 3 issues with protein synthesis inhibitors?
- need access to ribosomes
- mode of resistance is antibiotic efflux and reduced uptake by bacteria
- bacterial-produced enzymatic deactivation
Bacterial Protein Synthesis Step 1
charged tRNA unit delivers an amino acid to acceptor site on 70S ribosome
Bacterial Protein Synthesis Step 2
tRNA at the donor site, with an amino acid chain binds the growing chain to a new amino acid
Bacterial Protein Synthesis Step 3
uncharged tRNA left at donor site is released
Bacterial Protein Synthesis Step 4
new amino acid chain w/ tRNA is translocated to peptidyl side
Tetracyclines and Aminoglycosides affect which step in bacterial protein synthesis?
Step 1 - bind the 30S subunit and prevent the binding of incoming charged tRNA unit
Macrolides, Clindamycin, and Chloramphenicol affect which step in bacterial protein synthesis?
Step 2 - bind tot he 50S subunit and block peptide bond formation
Target 30S subunit (2)
- aminoglycosides
- gentamicin, amikacin, tobramycin, neomycin, streptomycin - tetracyclines
- doxycycline, tetracycline, tigecycline(IV), minocycline
Target 50S subunit (5)
- lincosamides
- clindamycin - Macrolides
- azithromycin, clarithromycin, erythromycin - Streptogramins
- quinupristin/dalfopristin(IV) - Oxazolidinones
- linezolid - Amphenicols
- chloramphenicol
Aminoglycosides (ANGST) MOA
ANGST: amikacin, neomycin, gentamicin, streptomycin, tobramycin
- broad-spectrum
- bind to 30S subunit = prevent initiation of protein synthesis–> causing misreading of RNA
- bacteriostatic
Aminoglycosides are primarily used against gram ________
negative bacilli–> E. coli, Klebsiella pneumoniae, P. aeruginosa
Aminoglycosides are toxic to the ______ and ______.
kidney and inner ear - binds to renal tissue and may reach toxic concentrations in kidney and inner ear (neomycin and streptomycin)
How are aminoglycosides administered? Half-life?
parenterally –> IV, IM
2-3hrs
Aminoglycosides: excretion
excreted unchanged in the urine
Aminoglycosides: ADRs
- ototoxicity: balance/vertigo, deafness
- neurotoxicity: blockade of presynaptic release of ACh at NMJ and postsynaptic blockade–> weakness and respiratory depression
- hypersensitivity rxns
Aminoglycosides: Contraindications
myasthenia gravis; also avoid w/ pregnancy
Tetracyclines: Names and MOA
- doxycycline, tigecycline(IV), minocycline, tetracycline
- broad-spectrum against gram +/-
- bind reversibly to 30 S subunit –> preventing tRNA from binding to the mRNA-ribosome complex
How does resistance to tetracyclines occur? (3)
- acquire efflux pathways
- produce protein blocking it from binding to ribosome
- enzymatically inactivate the drug
Tetracyclines: Spectrum
activity MSSA and MRSA
Tetracyclines: Don’t Take With?
Antacids and dairy–> antibiotics form chelates with divalent metal ions
Tetracyclines: Metabolism and Excretion
- hepatically
- feces and urine
Tetracyclines: DDIs
digoxin, CYP substrates(warfarin) or inducers(carbamazepine, alcohol, barbiturates, etc)